Indapamide Teva Sante

Indapamide, the active ingredient in Indapamide Teva Sante, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to control high blood pressure and to lessen fluid accumulation in patients with congestive heart failure.

GNH USA supplies Indapamide Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal tubular system to manage conditions related to fluid balance and vascular resistance. - Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of cardiovascular events. - Edema associated with congestive heart failure: increases urinary excretion of sodium and water, helping to relieve fluid overload. - Edema due to renal or hepatic disease (off‑label in some regions): promotes diuresis to decrease peripheral swelling.

Indapamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Electrolyte imbalance (e.g., low potassium or sodium). - Dizziness or light‑headedness, especially on standing. - Increased urination. - Headache. - Nausea or abdominal discomfort. - Fatigue.

Serious or Rare Side Effects: - Severe dehydration. - Acute gout attacks. - Allergic reactions such as rash, pruritus, or angioedema. - Blood dyscrasias (e.g., leukopenia, thrombocytopenia). - Pancreatitis. - Significant renal function decline.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor relevant parameters. - Monitor electrolytes: check serum potassium, sodium and magnesium regularly. - Assess renal function: evaluate creatinine clearance before and during treatment. - Use caution in diabetes: diuretics may affect glucose control. - Adjust dose in hepatic impairment: consider reduced clearance. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - NSAIDs: may reduce diuretic efficacy and impair renal function. - ACE inhibitors or ARBs: combined use can lead to excessive potassium loss.

Moderate Interactions (Monitor Closely): - Digoxin: altered serum levels due to electrolyte shifts. - Antidiabetic agents: may enhance hypoglycaemic effect. - Corticosteroids: additive sodium‑retaining effect, requiring electrolyte monitoring.